VentriPoint Diagnostics Ltd. (CVE:VPT – Get Free Report) shot up 29% during mid-day trading on Friday . The stock traded as high as C$0.20 and last traded at C$0.20. 414,232 shares changed hands during mid-day trading, an increase of 48% from the average session volume of 280,587 shares. The stock had previously closed at C$0.16.
VentriPoint Diagnostics Stock Up 16.1 %
The company has a debt-to-equity ratio of -58.56, a current ratio of 0.28 and a quick ratio of 6.67. The firm has a 50-day simple moving average of C$0.10 and a two-hundred day simple moving average of C$0.13. The company has a market cap of C$29.20 million, a PE ratio of -5.56 and a beta of 0.39.
About VentriPoint Diagnostics
Ventripoint Diagnostics Ltd., a medical device company, engages in the development and commercialization of diagnostic tools that monitor patients with heart disease worldwide. It offers Ventripoint Medical System (VMS), a medical imaging system that is used to generate three-dimensional models with critical volume and functional measurements of a patient’s heart chambers.
Further Reading
- Five stocks we like better than VentriPoint Diagnostics
- How to Choose Top Rated Stocks
- Is Myers Industries Poised for a Breakout?
- What is the Dow Jones Industrial Average (DJIA)?
- Is BigBear.ai’s 25% Plunge a False Alarm or Fire Sale?
- Health Care Stocks Explained: Why You Might Want to Invest
- Broadcom Confirmed Its AI Outlook: Stock to Hit New Highs Soon
Receive News & Ratings for VentriPoint Diagnostics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for VentriPoint Diagnostics and related companies with MarketBeat.com's FREE daily email newsletter.
